Technology Specific Research Papers
This category covers papers written about the recent technological advances in genomics, proteomics, metabolimcs, nutrigenomics that are utilised by the pharmaceutical industry to optimise drug development. It highlights advances in drug delivery technology, diagnostic devices and medical devices that aid drug development and prescription and encompasses new technologies such as gene therapy, antisense and RNAi that may revolutionise the development of future treatments.
Papers
 The Future of Cardiovascular Diagnostics:Impact of technological advances on growth opportunities and future market outlook Published: 1st March 2010 |
| The Future of Nutrigenomics: New opportunities in personalized nutrition and food-pharma collaboration Published: 18th January 2010 |
| Innovations In Epigenetics Advances in Technologies, Diagnostics & Therapeutics Published: 27th November 2009 |
| Key Players and Innovative Start-ups in Nutraceuticals Emerging strategies in ingredients, pharma, food and drinks Published: 2nd November 2009 |
| Innovations in Medical Imaging: Technological advances, growth opportunities and future market outlook Published: 24th August 2009 |
| Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success Published: 20th April 2009 |
| Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI Published: 2nd March 2009 |
| Delivering New Biopharmaceutical Therapies: Challenges & Opportunities Published: 19th January 2009 |
| Stem Cell-Based Therapeutic Delivery Challenges & Opportunities Published: 15th December 2008 |
| Innovative Strategies and Models for R&D Success: The evolving networked pharma company Published: 29th August 2008 |
| Cancer Biomarkers: Players, products and prospects Volume I Published: 28th August 2008 |
| CNS Biomarkers: Players, products and prospects Volume II Published: 28th August 2008 |
| Cardiovascular Biomarkers: Players, products and prospects Volume III Published: 28th August 2008 |
| Cancer Stem Cells Emerging Therapeutic, Diagnostic and Market Opportunities Published: 20th June 2008 |
| The Landscape of Companion Diagnostics: Challenges, Opportunities, and Future Trends Published: 1st June 2008 |
| Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers Published: 26th March 2008 |
| Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics Published: 2nd January 2008 |
| Drug Delivery Technology: Revolutionizing CNS Therapies Revolutionizing CNS Therapies Published: 13th December 2007 |
| Drug Delivery Technology: Developing a New Generation of Vaccines Developing a New Generation of Vaccines Published: 23rd November 2007 |
| Nucleic Acid Drug Delivery Technologies: Players, products & prospects to 2015 Published: 17th November 2007 |
| Targeted Drug Delivery Technologies: Players, products & prospects to 2015 Published: 17th November 2007 |
| Controlled-release Drug Delivery Technologies: Players, products & prospects to 2015 Published: 17th November 2007 |
| Nano-enabled Drug Delivery Technologies: Players, products & prospects to 2015 Published: 16th November 2007 |
| Translational Medicine in Biopharmaceutical R&D: Enabling R&D optimization and early detection of potential failures Published: 1st October 2007 |
| The Increasing Influence of Payers, Providers, and Patients on the U.S. Pharmaceutical Market Published: 1st October 2007 |
| Drug Delivery Technology: Revolutionizing Diabetes Treatment Revolutionizing Diabetes Treatment Published: 20th September 2007 |
| Drug Delivery Technology: Revolutionizing Cardiovascular Treatment Revolutionizing Cardiovascular Treatment Published: 9th July 2007 |
| Drug Repositioning Strategies Innovative strategies to boost pipeline productivity Published: 1st June 2007 |
| Outlook for RNAi 2007 siRNA and miRNA in biology, diagnostics and therapeutics Published: 1st June 2007 |
| Drug DeliveryTechnologies: Revolutionizing Cancer Therapies Revolutionizing Cancer Therapies Published: 1st May 2007 |
| Molecular Diagnostics Recent Advances in the Fast-Growing Molecular Diagnostics Industry Published: 16th March 2007 |
| Recent Advances in the Fast-Growing Molecular Diagnostics Industry Published: 16th March 2007 |
| Next Generation Nutriceuticals Food and Pharma convergence in disease prevention and personalized nutrition Published: 1st December 2006 |
| The Future of Metabolomics Building competitive advantage in drug discovery, clinical development and diagnostics. Published: 1st August 2006 |
| Big Pharma Embraces Pharmacogenomics But are we there yet Published: 1st August 2006 |
| Commercial Opportunities from Biomarkers. Transforming drug discovery, clinical development and molecular diagnostics. Published: 1st May 2006 |
| Lead Optimization Strategies Future developments, threats and opportunities for big pharma, speciality pharma and biotech. Published: 1st September 2005 |
| The Future Of Array Technologies Impact on drug discovery and market growth in DNA, protein and tissue arrays Published: 1st June 2005 |
| The Outlook for RNAi. Accelerating drug discovery and the development of RNAi therapeutics Published: 1st May 2005 |
| The Future of Personalized Medicine The impact of proteomics on drug discovery and clinical trial design Published: 1st October 2004 |
